ECM
BIO icon

Evergreen Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Evergreen Capital Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-742
Closed -$225K – 1524
2025
Q4 		$225K Buy
+742
New +$232K 0.01% 1231
2022
Q2 		– Sell
-835
Closed -$470K – 576
2022
Q1 		$470K Buy
835
+2
+0.2% +$1.21K 0.02% 391
2021
Q4 		$629K Sell
833
-5
-0.6% -$3.74K 0.03% 341
2021
Q3 		$625K Buy
838
+6
+0.7% +$4.5K 0.03% 330
2021
Q2 		$536K Buy
832
+3
+0.4% +$1.83K 0.03% 329
2021
Q1 		$473K Sell
829
-6
-0.7% -$3.55K 0.02% 326
2020
Q4 		$487K Buy
835
+53
+7% +$30.2K 0.03% 294
2020
Q3 		$403K Buy
782
+9
+1% +$4.56K 0.03% 285
2020
Q2 		$349K Buy
+773
New +$341K 0.03% 285

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return